7:15 a.m.

Virtual Event Opens & Colleague Networking

7:45 a.m.

Metastatic Evaluation of the Melanoma Patient
Douglas Winstanley, DO

8:15 a.m.

Treatment of Advanced Melanoma
Kathryn B. Bollin, MD

8:45 a.m.

Melanoma in the Molecular Age Part 1: New Tools for Diagnosis, Prognosis
Kathleen M. Murphy, PhD

9:15 a.m.

Break, Networking & View Exhibits

9:35 a.m.

Oncolytic Immunotherapy
Merrick I. Ross, MD

9:55 a.m.

Melanoma in the Molecular Age Part 2: New Tools for Diagnosis, Prognosis
Gregory A. Hosler, MD, PhD

10:25 a.m.

Melanoma: Medical Legal Complications
Robert A. Cosgrove, ESQ

10:45 a.m.

Cutaneous Toxicities of Immune Therapy
Aleksandr Itkin, MD

11:05 a.m.

Evaluation of the Melanoma Patient for Other Primary Melanoma Lesions
Frederick S. Fish, III, MD

11:25 a.m.

Case Presentations

Noon

Final Adjournment